Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

This publication has 26 references indexed in Scilit:

• Immunological localization of m1–m5 muscarinic acetylcholine receptors in peripheral tissues and brain
  Published by Elsevier ,2002
• The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo
  Life Sciences, 1993
• A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group
  JAMA, 1992
• Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats
  Psychopharmacology, 1992
• Tetrahydroaminoacridine facilitates passive avoidance learning in rats with nucleus basalts magnocellularis lesions
  Neuropharmacology, 1989
• E2020, a novel centrally acting acetylcholinesterase inhibitor (1): Inhibitory action on cholinesterase
  The Japanese Journal of Pharmacology, 1989
• Cholinergic modulation of memory in rats
  Psychopharmacology, 1985
• Electroconvulsive Therapy — A Current Perspective
  New England Journal of Medicine, 1984
• Memory retention: potentiation of cholinergic drug combinations in mice
  Neurobiology of Aging, 1983
• Central administration of the muscarinic receptor subtype - selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse
  Journal of Pharmacy and Pharmacology, 1983